Cargando…
Molecular pathways of major depressive disorder converge on the synapse
Major depressive disorder (MDD) is a psychiatric disease of still poorly understood molecular etiology. Extensive studies at different molecular levels point to a high complexity of numerous interrelated pathways as the underpinnings of depression. Major systems under consideration include monoamine...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540059/ https://www.ncbi.nlm.nih.gov/pubmed/36203007 http://dx.doi.org/10.1038/s41380-022-01806-1 |
_version_ | 1784803627933630464 |
---|---|
author | Fries, Gabriel R. Saldana, Valeria A. Finnstein, Johannes Rein, Theo |
author_facet | Fries, Gabriel R. Saldana, Valeria A. Finnstein, Johannes Rein, Theo |
author_sort | Fries, Gabriel R. |
collection | PubMed |
description | Major depressive disorder (MDD) is a psychiatric disease of still poorly understood molecular etiology. Extensive studies at different molecular levels point to a high complexity of numerous interrelated pathways as the underpinnings of depression. Major systems under consideration include monoamines, stress, neurotrophins and neurogenesis, excitatory and inhibitory neurotransmission, mitochondrial dysfunction, (epi)genetics, inflammation, the opioid system, myelination, and the gut-brain axis, among others. This review aims at illustrating how these multiple signaling pathways and systems may interact to provide a more comprehensive view of MDD’s neurobiology. In particular, considering the pattern of synaptic activity as the closest physical representation of mood, emotion, and conscience we can conceptualize, each pathway or molecular system will be scrutinized for links to synaptic neurotransmission. Models of the neurobiology of MDD will be discussed as well as future actions to improve the understanding of the disease and treatment options. |
format | Online Article Text |
id | pubmed-9540059 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-95400592022-10-11 Molecular pathways of major depressive disorder converge on the synapse Fries, Gabriel R. Saldana, Valeria A. Finnstein, Johannes Rein, Theo Mol Psychiatry Expert Review Major depressive disorder (MDD) is a psychiatric disease of still poorly understood molecular etiology. Extensive studies at different molecular levels point to a high complexity of numerous interrelated pathways as the underpinnings of depression. Major systems under consideration include monoamines, stress, neurotrophins and neurogenesis, excitatory and inhibitory neurotransmission, mitochondrial dysfunction, (epi)genetics, inflammation, the opioid system, myelination, and the gut-brain axis, among others. This review aims at illustrating how these multiple signaling pathways and systems may interact to provide a more comprehensive view of MDD’s neurobiology. In particular, considering the pattern of synaptic activity as the closest physical representation of mood, emotion, and conscience we can conceptualize, each pathway or molecular system will be scrutinized for links to synaptic neurotransmission. Models of the neurobiology of MDD will be discussed as well as future actions to improve the understanding of the disease and treatment options. Nature Publishing Group UK 2022-10-06 2023 /pmc/articles/PMC9540059/ /pubmed/36203007 http://dx.doi.org/10.1038/s41380-022-01806-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Expert Review Fries, Gabriel R. Saldana, Valeria A. Finnstein, Johannes Rein, Theo Molecular pathways of major depressive disorder converge on the synapse |
title | Molecular pathways of major depressive disorder converge on the synapse |
title_full | Molecular pathways of major depressive disorder converge on the synapse |
title_fullStr | Molecular pathways of major depressive disorder converge on the synapse |
title_full_unstemmed | Molecular pathways of major depressive disorder converge on the synapse |
title_short | Molecular pathways of major depressive disorder converge on the synapse |
title_sort | molecular pathways of major depressive disorder converge on the synapse |
topic | Expert Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540059/ https://www.ncbi.nlm.nih.gov/pubmed/36203007 http://dx.doi.org/10.1038/s41380-022-01806-1 |
work_keys_str_mv | AT friesgabrielr molecularpathwaysofmajordepressivedisorderconvergeonthesynapse AT saldanavaleriaa molecularpathwaysofmajordepressivedisorderconvergeonthesynapse AT finnsteinjohannes molecularpathwaysofmajordepressivedisorderconvergeonthesynapse AT reintheo molecularpathwaysofmajordepressivedisorderconvergeonthesynapse |